| 5.20 Data as of May 24 |  -0.06 / -1.14%Today’s Change | 4.06 Today|||52-Week Range 11.11 | -14.61% Year-to-Date |
| Previous close | 5.26 |
| Today’s open | 5.25 |
| Day’s range | 5.16 - 5.30 |
| Volume | 137,505 |
| Average volume (3 months) | 330,856 |
| Market cap | $499.7M |
| Dividend yield | -- |
| Earnings growth (last year) | +82.04% |
| Earnings growth (this year) | +19.14% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +42.98% |
| P/E ratio | NM |
| Price/Sales | 9.07 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| SGNTSagent Pharmaceutica... | -0.14 | -0.78% |
| SPPISpectrum Pharmaceuti... | -0.22 | -2.57% |
| ECYTEndocyte Inc | 0.00 | 0.00% |
| AVNRAvanir Pharmaceutica... | +0.01 | +0.29% |
| Next reporting date | August 9, 2013 |
| EPS forecast (this quarter) | -$0.27 |
| Annual revenue (last year) | $48.9M |
| Annual profit (last year) | -$91.3M |
| Net profit margin | -186.58% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Robert J. Mulroy |
Senior Vice President- Operations William M. McClements, MBA |
Corporate headquarters Cambridge, Massachusetts |
.
